leadf
logo-loader
viewTiziana Life Sciences PLC

Tiziana Life Sciences, Open Orphan, S4 Capital & planarTECH - Proactive's next virtual event

Proactive's head of UK events Thomas Coleman talks Andrew Scott through the line-up at this week's upcoming virtual event.

The companies attending include Tiziana Life Sciences PLC (LON:TILS), Open Orphan PLC (LON:ORPH), Sir Martin Sorrell from S4 Capital (LON:SFOR) as well as PlanarTECH.

Details to join the event can be found on the Proactive website ( www.proactiveinvestors.co.uk ) and by clicking on the events tab.

The information's also been pinned on the proactive twitter page (@proactive_UK)

Quick facts: Tiziana Life Sciences PLC

Price: 137 GBX

AIM:TILS
Market: AIM
Market Cap: £262.27 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tiziana Life Sciences PLC named herein, including the promotion by the Company of Tiziana Life Sciences PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Tiziana Life Sciences: Delivery method & data 'looks promising' ahead of...

Tiziana Life Sciences PLC (LON:TILS)(NASDAQ:TLSA) has announced plans to begin a clinical study of its nasally administered Foralumab in COVID-19 patients in Brazil. Proactive analyst Emma Ulker talks to Katie Pilbeam about the trial which will begin shortly with clinical data potentially...

1 week, 2 days ago

2 min read